Cila Therapeutics

Cila Therapeutics is a clinic-ready stage, a biotechnology company developing new inhaled therapies for respiratory diseases, leading with an inhaled treatment of a rare genetic disorder, Primary Ciliary Dyskinesia, or PCD.